NINE MONTHS RESULTS
Sun Pharmaceutical Industries Ltd.
BSE
Apr 30
1830.20
+25.40 (+ 1.41%)
Volume
34570
Prev. Close
1804.80
Open Price
1809.70
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
1832.30
+26.80 (+ 1.48%)
Volume
2667314
Prev. Close
1805.50
Open Price
1810.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Nine Months Results
for the last 5 years.
|
ISIN No
|
INE044A01036
|
Market Cap. ( ₹ in Cr. )
|
439630.15
|
P/BV
|
6.36
|
Book Value ( ₹ )
|
288.06
|
|
BSE Code
|
524715
|
52 Week High/Low ( ₹ )
|
1960/1377
|
FV/ML
|
1/1
|
P/E(X)
|
45.91
|
|
NSE Code
|
SUNPHARMAEQ
|
Book Closure
|
06/02/2025
|
EPS ( ₹ )
|
39.91
|
Div Yield (%)
|
0.74
|
(₹ in Crs.)
| Net Sales/Income from operations | 15518.74 | 14306.54 | 14593.78 | 11530.28 | 9451.89 |
| Other Operating Income | 298.85 | 329.49 | 270.14 | 48.82 | 191.68 |
| Total Income From Operations | 15817.59 | 14636.03 | 14863.92 | 11579.10 | 9643.57 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 3360.97 | 3373.51 | 3975.77 | 3298.73 | 2684.95 |
| Purchase of Traded Goods | 1033.83 | 704.91 | 864.10 | 1010.76 | 831.07 |
| Increase/Decrease in Stocks | -67.10 | 210.29 | -105.29 | -33.05 | 55.42 |
| Employees Cost | 1959.35 | 1797.98 | 1627.90 | 1502.84 | 1373.83 |
| Depreciation | 946.31 | 1207.58 | 1188.89 | 995.81 | 435.05 |
| Other Expenses | 5727.38 | 4855.26 | 4389.23 | 3892.14 | 2442.55 |
| Total Expenses | 12960.74 | 12149.53 | 11940.60 | 10667.23 | 7822.87 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 2856.85 | 2486.50 | 2923.32 | 911.87 | 1820.70 |
| Other Income | 237.43 | 346.88 | 158.73 | 657.51 | 115.35 |
| P/L Before Interest, Excpt. Items & Tax | 3094.28 | 2833.38 | 3082.05 | 1569.38 | 1936.05 |
| Interest | 675.79 | 566.49 | 310.73 | 296.91 | 154.25 |
| P/L Before Exceptional Items & Tax | 2418.49 | 2266.89 | 2771.32 | 1272.47 | 1781.80 |
| Exceptional Items | 0.00 | -219.02 | 0.00 | -165.57 | 0.00 |
| P/L Before Tax | 2418.49 | 2047.87 | 2771.32 | 1106.90 | 1781.80 |
| Tax | 136.33 | 57.29 | 59.78 | -79.32 | -30.51 |
| P/L After Tax from Ordinary Activities | 2282.16 | 1990.58 | 2711.54 | 1186.22 | 1812.31 |
| Net Profit/Loss For the Period | 2282.16 | 1990.58 | 2711.54 | 1186.22 | 1812.31 |
| | | | | | |
| Equity Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 9.50 | 8.30 | 11.30 | 4.90 | 7.55 |
| Diluted EPS (Rs.) | 9.50 | 8.30 | 11.30 | 4.90 | 7.55 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 9.50 | 8.30 | 11.30 | 4.90 | 7.55 |
| Diluted EPS (Rs.) | 9.50 | 8.30 | 11.30 | 4.90 | 7.55 |
| | | | | | |
| PBITOE Margin (%) | 18.06 | 16.98 | 19.66 | 7.87 | 18.87 |
| PBTE Margin (%) | 15.28 | 15.48 | 18.64 | 10.98 | 18.47 |
| PBT Margin (%) | 15.28 | 13.99 | 18.64 | 9.55 | 18.47 |
| PAT Margin (%) | 14.42 | 13.60 | 18.24 | 10.24 | 18.79 |